Search research articles
Contact Us
Filters
Showing results (231-240 of 262) with videos related to
Page
of 27
Sort By:
Open Forum Infectious Diseases
|
July 18, 2024
Missed Opportunities for Preexposure Prophylaxis Initiation in Hospitalized Persons With Opioid Use Disorder and Infectious Diseases
Kaley Parchinski, Victor Neirinckx, Cynthia Frank, et al.
European Addiction Research
|
June 22, 2020
Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders
Natalie C Sánchez-García, Rafael A González, Josep A Ramos-Quiroga, et al.
JAMA Network Open
|
May 30, 2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical Trial
Nikhil Seval, Prerana Roth, Cynthia A Frank, et al.
BMJ Open
|
November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings
Liam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 15, 2025
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies
Samuele Cortese, Mark A Bellgrove, Isabell Brikell, et al.
Contemporary Clinical Trials
|
September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network
Erin A McClure, Susan C Sonne, Theresa Winhusen, et al.
The International Journal of Social Psychiatry
|
June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)
Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)
Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The Journal of Clinical Psychiatry
|
December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)
Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Drug and Alcohol Dependence
|
June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
Kevin M Gray, Susan C Sonne, Erin A McClure, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 262) with videos related to
Sort By:
Page
of 27
Open Forum Infectious Diseases
|
July 18, 2024
Missed Opportunities for Preexposure Prophylaxis Initiation in Hospitalized Persons With Opioid Use Disorder and Infectious Diseases
Kaley Parchinski, Victor Neirinckx, Cynthia Frank, et al.
European Addiction Research
|
June 22, 2020
Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders
Natalie C Sánchez-García, Rafael A González, Josep A Ramos-Quiroga, et al.
JAMA Network Open
|
May 30, 2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical Trial
Nikhil Seval, Prerana Roth, Cynthia A Frank, et al.
BMJ Open
|
November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings
Liam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 15, 2025
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies
Samuele Cortese, Mark A Bellgrove, Isabell Brikell, et al.
Contemporary Clinical Trials
|
September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network
Erin A McClure, Susan C Sonne, Theresa Winhusen, et al.
The International Journal of Social Psychiatry
|
June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)
Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)
Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The Journal of Clinical Psychiatry
|
December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)
Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Drug and Alcohol Dependence
|
June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
Kevin M Gray, Susan C Sonne, Erin A McClure, et al.
Page
of 27